|Born||23 March 1924|
Katlakalns, Riga, Latvia
|Died||14 February 2010 (aged 85)|
|Alma mater||Latvian State University, Faculty of Medicine|
|Occupation||Scientist, inventor of RIGVIR|
Life and work
Aina Muceniece was born in Katlakalns, Latvia. She graduated 1941 from the Vilis Olavs School of Commerce in Riga and worked as a nurse during World War II in Yaroslavl, USSR. After the war, she studied medicine at the Latvian State University, where she earned a doctor's degree in 1974. Muceniece achieved habilitation (Dr.habil.med.) in 1992.
Muceniece's scientific career began at the August Kirhenstein Institute of Microbiology, Latvian Academy of Sciences (Latvian: LZA Augusta Kirhenšteina Mikrobioloģijas institūts), first as a senior laboratory assistant, later as a senior research associate. Muceniece's laboratory started to study enteroviruses in the 1960s, and the research led to the identification of an echovirus that had possible use to treat melanoma, which became RIGVIR. Production and research was discontinued in 1999 and restarted after national registration in Latvia in 2004.
- "Aina Muceniece". Latvian Academy of Sciences. Retrieved 20 April 2018.
- "Aina Muceniece" (in Latvian). Latvian Academy of Sciences. Retrieved 20 April 2018.
- Eduards Ritums (October 2016). "When Science Takes A Back Seat". Skeptiskā biedrība. Retrieved 20 April 2018.
- LETA (15 February 2010). "Mūžībā aizgājusi medicīnas doktore un pretvēža medikamenta «Rigivir» izgudrotāja Muceniece" (in Latvian). Zemgales Ziņas. Retrieved 20 April 2018.
2002.gadā saņēmusi apbalvojumu kā Latvijas onkologu asociācijas goda locekle
- Jana Gavare (27 June 2009). "Latvija var! Medicīna ir mīlestība" (in Latvian). Dienas Bizness. Retrieved 20 April 2018.
Apbalvojumi: LR Atzinības krusts par sevišķiem nopelniem Latvijas valsts labā (2005)